targeted oncology

Takeda gets a win for its Wave1 pipeline, as Exkivity nabs FDA approval

https://pharmaphorum.com/news/takeda-gets-a-win-for-its-wave1-pipeline-as-exkivity-nabs-fda-approval/

Servier gets a win for cancer drug Tibsovo, bought in $1.8bn Agios deal

https://pharmaphorum.com/news/servier-gets-a-win-for-cancer-drug-tibsovo-bought-in-1-8bn-agios-deal/

NICE changes its mind on rare bile duct cancer drug from Incyte

https://pharmaphorum.com/news/nice-changes-its-mind-on-rare-bile-duct-cancer-drug-from-incyte/

Janssen claims FDA okay for would-be Tagrisso rival Rybrevant

https://pharmaphorum.com/news/janssen-claims-swift-fda-okay-for-precision-cancer-drug-rybrevant/

Cytokine-Based Cancer Immunotherapies Summit

https://pharmaphorum.com/events/cytokine-based-cancer-immunotherapies-summit/

Close in 10 seconds

Pharmaphorum.com

Search